Stories > BeiGene's Tislelizumab: CHMP Approval Triumph

BeiGene's Tislelizumab: CHMP Approval Triumph

Advancements in Cancer Treatment and Mar...

Advancements in Lymphoma Treatments

Cancer Advances Showcased at AACR 2024

Aadi Bioscience Validates FYARRO® for PE...

Advancing CD70 Targeted Cancer Treatment...

Aldeyra Therapeutics R&D Day 2024